EssilorLuxottica (OTCMKTS:ESLOY) Sees Large Volume Increase – Still a Buy?
by Danessa Lincoln · The Markets DailyEssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY – Get Free Report) saw unusually-strong trading volume on Tuesday . 64,803 shares were traded during trading, a decline of 48% from the previous session’s volume of 123,702 shares.The stock last traded at $92.77 and had previously closed at $92.8350.
Analysts Set New Price Targets
A number of brokerages have issued reports on ESLOY. The Goldman Sachs Group downgraded EssilorLuxottica from a “buy” rating to a “hold” rating in a report on Tuesday, July 14th. Deutsche Bank Aktiengesellschaft started coverage on shares of EssilorLuxottica in a report on Tuesday, May 12th. They set a “hold” rating for the company. Finally, Zacks Research upgraded shares of EssilorLuxottica from a “strong sell” rating to a “hold” rating in a research note on Tuesday, August 18th. Two analysts have rated the stock with a Strong Buy rating, four have issued a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, EssilorLuxottica presently has a consensus rating of “Moderate Buy”.
View Our Latest Stock Analysis on ESLOY
EssilorLuxottica Stock Performance
The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.70 and a current ratio of 0.99. The firm’s 50 day moving average price is $95.73 and its 200-day moving average price is $108.04.
About EssilorLuxottica
EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.
The company’s product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.